Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-127846
Filing Date
2024-11-18
Accepted
2024-11-18 12:10:14
Documents
93
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rgen-20240930.htm   iXBRL 10-Q 3920813
2 EX-31.1 rgen-ex31_1.htm EX-31.1 14452
3 EX-31.2 rgen-ex31_2.htm EX-31.2 14459
4 EX-32.1 rgen-ex32_1.htm EX-32.1 17881
  Complete submission text file 0000950170-24-127846.txt   19236236

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rgen-20240930.xsd EX-101.SCH 2027163
95 EXTRACTED XBRL INSTANCE DOCUMENT rgen-20240930_htm.xml XML 5030273
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-14656 | Film No.: 241470444
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)